Product Information
LABETALOL HCL 300 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.2157 per EA under NDC 62135080060. Its NADAC has been published 138 times since Jan 3, 2024.
FDA first approved this application on Aug 3, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Chartwell RX LLCNDC
62135080060
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LABETALOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074787FDA Approved
8/3/1998
TE Code
AB
On Market Since
2/22/2020
Pharmacological Classes
Price Statistics
The NADAC for LABETALOL HCL 300 MG TABLET has been published 138 times since Jan 3, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2157 per EA |
|---|---|
| All-time high | $0.2251 (Apr 10, 2024) |
| All-time low | $0.1776 (Nov 20, 2024) |
| 52-week high | $0.2157 |
| 52-week low | $0.2041 |
| Median price | $0.2071 |
| Average price | $0.2060 |
| Largest weekly change | -16.9% (Jul 17, 2024) |
| Weeks tracked | 138 |
| Tracking since | Jan 3, 2024 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LABETALOL HCL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LABETALOL HCL 300 MG TABLET, manufactured by Chartwell RX LLC, is $0.2157 per EA (NDC 62135080060), effective Aug 19, 2026.
How has the price of LABETALOL HCL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for LABETALOL HCL 300 MG TABLET has held within roughly two percent of its current level. It has been tracked across 138 weekly CMS publications since Jan 3, 2024.
What are the highest and lowest recorded NADAC prices for LABETALOL HCL 300 MG TABLET?
Since Jan 3, 2024, the NADAC for LABETALOL HCL 300 MG TABLET has ranged from a low of $0.1776 (Nov 20, 2024) to a high of $0.2251 (Apr 10, 2024), with a median of $0.2071 per EA.
Are there cheaper alternatives to LABETALOL HCL 300 MG TABLET?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LABETALOL HCL 300 MG TABLET, is $0.2041 per EA — about 5% below LABETALOL HCL 300 MG TABLET.
Who manufactures LABETALOL HCL 300 MG TABLET?
LABETALOL HCL 300 MG TABLET (NDC 62135080060) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.